Jump to content

Drilldown: Medicines

Pharmacopedia
BrowseCategoriesLog in

Choose a table:


Medicines > routes: Intravenous (continuous infusion in a REMS-certified facility) & onset : Antidepressant effect within hours of infusion start; sustained at 30 days or Postprandial glucose effect within days; HbA1c by 12 weeks

Use the filters below to narrow your results.

generic:
None (1)
brand:
Zulresso (1)
classes:
GABA-A positive allosteric modulator (1) · Neuroactive steroid (1)
mechanism:
None (1)
uses:
Postpartum depression (PPD) in adults (1)
starting dose:
Single 60-hour continuous IV infusion: 30 mcg/kg/h × 4h → 60 mcg/kg/h × 20h → 90 mcg/kg/h × 28h → 60 mcg/kg/h × 4h → 30 mcg/kg/h × 4h (1)
preparations:
100 mg/20 mL vial, single-use (1)
fda max:
Single 60-hour course (1)
routes: (Click arrow to add another value)
onset: (Click arrow to add another value)
duration:
Single infusion course (1)
halflife:
~9 hours (terminal) (1)
bioavailability:
100% (IV) (1)
pregnancy:
Medicine is structurally identical to endogenous allopregnanolone; pregnancy considerations relate to breastfeeding during/after infusion. Limited data; brief interruption of breastfeeding considered (1)
legal:
Rx; REMS program required (excessive sedation/loss of consciousness during infusion) (1)

Showing below up to 1 result in range #1 to #1.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"